FDA Inspection
Sartorius Stedim Biooutsource LimitedSartorius Stedim Biooutsource Limited – FDA Inspection, Sep 5, 2025
Record Details
This FDA Inspection record concerns Sartorius Stedim Biooutsource Limited, with an inspection on September 5, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · a33b26c1-5b43-4cd1-baa4-f3599f76fbed
Inspection Facts
- Inspection number
- 1285976
- FDA center
- Human Drugs
Other FDA inspections of Sartorius Stedim Biooutsource Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 6, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 13, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 26, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sartorius Stedim Biooutsource Limited
- FDA Inspection 1152873 - 2019-12-11
- FDA Inspection 1086614 - 2019-03-06
- FDA Inspection 1029992 - 2017-09-13
- FDA Inspection 956573 - 2016-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.